Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829406) titled 'A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy People' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Healthy Volunteers
Intervention:
Drug: NNC0642-1895
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 17, 2026
Target Sample Size: 148
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov...